In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,090 | -19,440 | -14,498 | -10,644 | -5,550 |
| Depreciation Amortization | 500 | 2,501 | 1,980 | 1,453 | 669 |
| Accounts payable and accrued liabilities | 140 | -80 | -185 | -10 | 186 |
| Other Working Capital | -758 | 1,038 | -533 | 356 | 928 |
| Other Operating Activity | 261 | 3,269 | 2,663 | 1,796 | 645 |
| Operating Cash Flow | $-4,947 | $-12,712 | $-10,573 | $-7,049 | $-3,122 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-9 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -107 | -693 | -582 | -459 | -225 |
| Common Stock Issued | N/A | 29,331 | 2,267 | 9,619 | 4,118 |
| Other Financing Activity | -88 | 0 | 8,464 | 0 | 0 |
| Financing Cash Flow | $-195 | $28,638 | $10,149 | $9,160 | $3,893 |
| Beginning Cash Position | 27,312 | 11,386 | 11,386 | 11,386 | 11,386 |
| End Cash Position | 22,161 | 27,312 | 10,962 | 13,497 | 12,157 |
| Net Cash Flow | $-5,151 | $15,926 | $-424 | $2,111 | $771 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,947 | -12,712 | -10,573 | -7,049 | -3,122 |
| Capital Expenditure | -9 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,956 | -12,712 | -10,573 | -7,049 | -3,122 |